Introduction: HIK1083 and MUC6 have been used as immunohistochemical markers to differentiate gastric-type adenocarcinoma (GTAC) from other endocervical adenocarcinomas. We aimed to assess their diagnostic accuracy through a systematic review and meta-analysis. Methods: Three electronic databases were searched from their inception to July 2022 for all studies assessing the expression in endocervical GTAC vs other endocervical adenocarcinomas. Diagnostic accuracy was assessed as sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), diagnostic odds ratio (DOR), and area under the curve (AUC) on SROC curves. Results: Four studies with 343 patients were included. HIK1083 showed sensitivity= 0.64, specificity= 0.94, LR+ =8.30, LR-= 0.38, DOR= 33.36, AUC= 89.9%. MUC6 showed sensitivity= 0.51, specificity= 0.74, LR+ =1.96, LR-= 0.71, DOR= 3.48, AUC= 72.8%. Conclusion: HIK1083 showed high specificity and low sensitivity as a marker of GTAC, with moderate overall accuracy; MUC6 showed moderate specificity and low sensitivity, with low overall accuracy.

Diagnostic accuracy of HIK1083 and MUC6 as immunohistochemical markers of endocervical gastric-type adenocarcinoma: A systematic review and meta-analysis / Fulgione, Caterina; Raffone, Antonio; Travaglino, Antonio; Arciuolo, Damiano; Santoro, Angela; Cianfrini, Federica; Russo, Daniela; Varricchio, Silvia; Raimondo, Ivano; Inzani, Frediano; Mollo, Antonio; Guida, Maurizio; Mascolo, Massimo; Zannoni, Gian Franco. - In: PATHOLOGY, RESEARCH AND PRACTICE. - ISSN 1618-0631. - 241:(2023), p. 154261. [10.1016/j.prp.2022.154261]

Diagnostic accuracy of HIK1083 and MUC6 as immunohistochemical markers of endocervical gastric-type adenocarcinoma: A systematic review and meta-analysis

Fulgione, Caterina;Raffone, Antonio;Travaglino, Antonio;Santoro, Angela;Russo, Daniela;Varricchio, Silvia;Mollo, Antonio;Guida, Maurizio;Mascolo, Massimo;
2023

Abstract

Introduction: HIK1083 and MUC6 have been used as immunohistochemical markers to differentiate gastric-type adenocarcinoma (GTAC) from other endocervical adenocarcinomas. We aimed to assess their diagnostic accuracy through a systematic review and meta-analysis. Methods: Three electronic databases were searched from their inception to July 2022 for all studies assessing the expression in endocervical GTAC vs other endocervical adenocarcinomas. Diagnostic accuracy was assessed as sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), diagnostic odds ratio (DOR), and area under the curve (AUC) on SROC curves. Results: Four studies with 343 patients were included. HIK1083 showed sensitivity= 0.64, specificity= 0.94, LR+ =8.30, LR-= 0.38, DOR= 33.36, AUC= 89.9%. MUC6 showed sensitivity= 0.51, specificity= 0.74, LR+ =1.96, LR-= 0.71, DOR= 3.48, AUC= 72.8%. Conclusion: HIK1083 showed high specificity and low sensitivity as a marker of GTAC, with moderate overall accuracy; MUC6 showed moderate specificity and low sensitivity, with low overall accuracy.
2023
Diagnostic accuracy of HIK1083 and MUC6 as immunohistochemical markers of endocervical gastric-type adenocarcinoma: A systematic review and meta-analysis / Fulgione, Caterina; Raffone, Antonio; Travaglino, Antonio; Arciuolo, Damiano; Santoro, Angela; Cianfrini, Federica; Russo, Daniela; Varricchio, Silvia; Raimondo, Ivano; Inzani, Frediano; Mollo, Antonio; Guida, Maurizio; Mascolo, Massimo; Zannoni, Gian Franco. - In: PATHOLOGY, RESEARCH AND PRACTICE. - ISSN 1618-0631. - 241:(2023), p. 154261. [10.1016/j.prp.2022.154261]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/922573
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact